Stockscreener 앱 받기
3.79
4.53%
-0.18
시간 외 거래:
3.77
-0.02
-0.53%
Organogenesis Holdings Inc 주식(ORGO)의 최신 뉴스
About Us - FinancialContent
The Market Doesn't Like What It Sees From Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Revenues Yet As Shares Tumble 28% - simplywall.st
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc.ORGO - Your Wyoming Link
Hedge Fund Bets: Is Organogenesis Holdings Inc benefiting from innovation trendsDay Trade & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc.ORGO - FinancialContent
Published on: 2026-01-13 05:15:38 - baoquankhu1.vn
Is Organogenesis Holdings (NASDAQ:ORGO) In A Good Position To Invest In Growth? - Sahm
Organogenesis drops as Medicare to pull skin substitute LCDs (update) - MSN
Is Organogenesis Holdings Inc. (2PQ) stock protected from inflationJuly 2025 Action & Free Technical Pattern Based Buy Signals - Улправда
Is Organogenesis Holdings Inc. stock a buy in volatile markets2025 Top Decliners & Growth Oriented Trade Recommendations - Улправда
What margin trends mean for Organogenesis Holdings Inc. stockIPO Watch & Pattern Based Trade Signal System - Улправда
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis ... - Bluefield Daily Telegraph
User - FinancialContent
Workboat Indexes | WorkBoatINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc.ORGO - FinancialContent
ORGOOrganogenesis Hldgs Inc Latest Stock News & Market Updates - Stock Titan
Three rising investors just landed bigger roles at a healthcare PE firm - Stock Titan
Organogenesis (NASDAQ:ORGO) Trading Down 5% – Time to Sell? - Defense World
Organogenesis (NASDAQ:ORGO) Shares Down 5%Here's What Happened - MarketBeat
Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring 64% Potential Upside Amidst Strong Revenue Growth - DirectorsTalk Interviews
Organogenesis Holdings extends leases for Canton facilities through 2032 By Investing.com - Investing.com Australia
Organogenesis Holdings extends leases for Canton facilities through 2032 - Investing.com
Organogenesis Extends Long-Term Leases for Key Facilities - TipRanks
Organogenesis (NASDAQ:ORGO) Shares Gap DownTime to Sell? - MarketBeat
Organogenesis' (ORGO) "Buy" Rating Reiterated at BTIG Research - MarketBeat
Organogenesis stock holds Buy rating at BTIG after CMS LCD decision - Investing.com Australia
Organogenesis stock holds Buy rating at BTIG after CMS LCD decision By Investing.com - Investing.com South Africa
Organogenesis begins FDA rolling review for knee arthritis treatment - Investing.com India
Organogenesis Initiates BLA Submission For ReNu In Knee Arthritis - Nasdaq
Organogenesis begins FDA rolling review for knee arthritis treatment By Investing.com - Investing.com Nigeria
Organogenesis starts rolling submission for ReNu allograft for knee arthritis - Seeking Alpha
Organogenesis stock rises after initiating FDA application for knee arthritis treatment By Investing.com - Investing.com South Africa
Organogenesis stock rises after initiating FDA application for knee arthritis treatment - Investing.com Nigeria
Organogenesis Announces Initiation of Biologics License Application for ReNu® - The Manila Times
Organogenesis Holdings Inc. Initiates Biologics License Application for ReNu® to Address Knee Osteoarthritis Pain - Quiver Quantitative
Biologic treatment for knee arthritis pain begins FDA license bid - Stock Titan
Gains Recap: Is Organogenesis Holdings Inc stock dividend yield sustainableWeekly Gains Report & Fast Gaining Stock Strategy Reports - moha.gov.vn
Net current asset value per share of Organogenesis Holdings, Inc. Class A – BER:2PQ - TradingView — Track All Markets
BTIG reiterates Organogenesis Holdings (ORGO) buy recommendation - MSN
Is Organogenesis Holdings Inc. stock a bargain at current levels2025 Momentum Check & Advanced Technical Analysis Signals - Улправда
Assenagon Asset Management S.A. Has $20.49 Million Stock Position in Organogenesis $ORGO - MarketBeat
Organogenesis (NASDAQ:ORGO) Shares Down 3.7% on Insider Selling - MarketBeat
Organogenesis Holdings Inc. (ORGO) Stock Analysis: 47% Potential Upside Sparks Investor Interest - DirectorsTalk Interviews
Is Organogenesis Holdings Inc. stock dividend yield sustainableJuly 2025 Outlook & Breakout Confirmation Trade Signals - DonanımHaber
Is Organogenesis Holdings Inc. stock supported by strong cash flows2025 Price Targets & Free Safe Capital Growth Stock Tips - Улправда
Organogenesis (NASDAQ:ORGO) Director Glenn Nussdorf Sells 200,000 Shares - MarketBeat
1.30%
1.45%
자본화:
|
볼륨(24시간):